Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03094026 · ClinicalTrials.gov registry record · NA

Cognitive Training Intervention and Attitudes Towards Genetics

A NA study of Cognitive Impairment and Hematologic Neoplasms, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT03094026 is a NA study of Cognitive Impairment and Hematologic Neoplasms that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 60 participants, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03094026, a NA study of Cognitive Impairment and Hematologic Neoplasms, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

A pilot study to evaluate feasibility of enrollment of patients in an intervention to improve neurocognitive function in hematopoietic cell transplantation (HCT) survivors using the cognitive training Lumosity program. In addition, patients' interest in receiving information regarding genetic risk of cognitive impairment post-HCT will be measured.

Interventions

  • BEHAVIORAL Lumosity
  • BEHAVIORAL Lumosity (waitlist control)

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2017-08-21
Est. Completion 2026-07
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT03094026

The ClinicalTrials.gov registry entry for NCT03094026 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (91% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Lumosity is the first listed.

NCT03094026 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT03094026 about?

NCT03094026 is a clinical study titled "Cognitive Training Intervention and Attitudes Towards Genetics". A pilot study to evaluate feasibility of enrollment of patients in an intervention to improve neurocognitive function in hematopoietic cell transplantation (HCT) survivors using the cognitive training Lumosity program. In addition, patients' interest in receiving information regarding genetic risk o...

What is the current status of trial NCT03094026?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2017-08-21. Estimated completion is 2026-07.

What conditions does trial NCT03094026 study?

This clinical trial studies the following conditions: Cognitive Impairment, Hematologic Neoplasms, Hematopoietic Cell Transplant.

What interventions are being tested in trial NCT03094026?

The interventions under investigation include: Lumosity (BEHAVIORAL), Lumosity (waitlist control) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03094026?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03094026 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.